ResMed Inc (ASX:RMD) director Harjit Gill disposed of 35.731 shares of ResMed common stock on 11 November 2026 at a price of $234.11 per share, according to a Statement of Changes in Beneficial Ownership filed with the United States Securities and Exchange Commission.
Key Points
- Director Harjit Gill disposed of 35.731 shares of ResMed common stock on 11 November 2026 at $234.11 per share
- The disposition was made to the issuer for tax withholding purposes on the vesting of Restricted Stock Units granted on 20 November 2025
- Following the transaction, Gill beneficially owns 10,904 shares of ResMed common stock directly
- The filing was signed by Harjit Gill on 13 November 2026
Transaction Details and Share Disposition
According to the filing, the transaction was recorded under code "F," indicating a disposition to the issuer. Harjit Gill, identified as a director of ResMed Inc, disposed of 35.731 shares of ResMed common stock at a price of $234.11 per share. The transaction date is recorded as 11 November 2026. The filing was submitted pursuant to Section 16(a) of the Securities Exchange Act of 1934 and was filed by one reporting person. No derivative securities were reported as acquired, disposed of, or beneficially owned in connection with this filing.
Tax Withholding on Restricted Stock Unit Vesting
The filing's explanation of responses states that the disposition was made to the issuer for tax withholding purposes on the vesting of Restricted Stock Units. Those Restricted Stock Units were originally granted on 20 November 2025. The shares disposed of represent a direct ownership interest, as indicated in the filing. This type of transaction, coded as "F," reflects a withholding of shares by the issuer to cover the tax obligations arising from the vesting event rather than an open-market sale by the director.
Remaining Beneficial Ownership Following the Transaction
Following the reported transaction, Harjit Gill holds 10,904 shares of ResMed common stock, as disclosed in the filing. The ownership is recorded as direct. No indirect beneficial ownership was reported in connection with this filing. The form was filed individually by Harjit Gill as a single reporting person. The filing does not disclose any derivative securities held by Gill following the transaction, and Table II of the form contains no entries relating to derivative securities such as options, warrants, or convertible securities.



Please wait processing your request...